I13 promotes cell differentiation by HDAC inhibition coupled with block of chronic myeloid leukemia signaling pathway in BCR-ABL T315I mutation CML cells. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.